Please assess the completion status of the following clinical trial:

Trial Title: Hematoma Block as an Adjunct to Procedural Sedation for Forearm Fracture Reduction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* English or Spanish speaking~* Ages 3-17~* Closed distal forearm fracture requiring reduction under sedation in the Emergency Department~* Fracture involves the distal third of the forearm~Exclusion Criteria:~* Multiple trauma victims~* Associated nerve or vascular damage~* Associated elbow or humerus injury~* Sensitivity or allergy to lidocaine~* Contraindications to procedural sedation~* Previous attempts at reduction for the same injury

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Lidocaine (Type: EXPERIMENTAL): Subjects randomly assigned to this arm will receive 2% lidocaine by injection into their fracture site in the form of a hematoma block.
- Normal Saline (Type: PLACEBO_COMPARATOR): Subjects randomly assigned to this arm will receive normal saline by injection into their fracture site

Based on this trial design, predict the completion outcome and termination type (if applicable).